The Indian Council of Medical Research (ICMR), in collaboration with the Drugs for Neglected Diseases initiative (DNDi) and the Foundation for Innovative New Diagnostics (FIND), organizes a virtual workshop on “Improving the current diagnostics for field us in visceral leishmaniasis and post-kala-azar dermal leishmaniasis (PKDL)”.
The objectives of the workshop is to review the current landscape of new tools in diagnostic and sample collection for visceral leishmaniasis and PKDL and prioritize the diagnostic tests for visceral leishmaniasis and PKDL for further development and recommend the next steps for validation and product development.
Workshop
Date: 23 September 2020
Time: 14:00-16:30
| Welcome address Samiran Panda, National Institute of Cholera and Enteric Diseases | ||
| Introduction and objective of the workshop Manju Rahi, Indian Council of Medical Research, India | ||
| Session 1: Current landscape of molecular and antigen detection tools for PKDL and VL diagnosis Moderator: Shyam Sundar, Institute of Medical Sciences, Banaras Hindu University, India and Mitali Chatterjee, Institute of Postgraduate Medical Education & Research (IPGMER), India Speakers: – Isra Cruz, Foundation for Innovative New Diagnostics (FIND) – Albert Picado, Foundation for Innovative New Diagnostics (FIND) – Ruchi Singh, National Institute of Pathology, Indian Council of Medical Research, India | ||
| Panel discussion Moderators: Poonam Salhotra, National Institute of Pathology, Indian Council of Medical Research, India and Fabiana Alves, Head of Visceral Leishmaniasis Clinical Programme, DNDi Speakers: – Nupur Roy, National Vector Borne Disease Control Program, India – Manju Rahi, Indian Council of Medical Research, India – Ruchi Singh, National Institute of Pathology, Indian Council of Medical Research, India – Albert Picado, Foundation for Innovative New Diagnostics (FIND) – O P Singh, Institute of Medical Sciences, Banaras Hindu University, India – Krishna Pandey, Rajendra Memorial Research Institute of Medical Sciences, Indian Council of Medical Research, India – Kayla Laserson, Bill & Melinda Gates Foundation (BMGF) | ||
| Conclusions and next steps Suman Rijal, Director of Regional Office, DNDi in India |
